Professional Documents
Culture Documents
Creating Excellence
Through Innovation
TABLE OF CONTENT
SECTION 1
Enseval In Brief
SECTION 2
Business Overview
SECTION 3
Operational Overview
20
SECTION 4
Financial Overview
23
SECTION 5
2015 Overview
28
SECTION 1
ENSEVAL IN BRIEF
ENSEVAL IN BRIEF
Integrated healthcare Distribution and Logistic services company through Service Excellence,
Technology Driven and Strong Leadership.
Established in October 1973 with the aim of managing the distribution function because of the
separation of the distribution division from the marketing and production division of PT Kalbe
Farma;
On 1 August 1994, the Company listed its shares on the Jakarta Stock Exchange;
The Company focuses its activities on distribution and trading services under 5 divisions :
Pharmaceutical products sales and distribution, which comprised of patented medicines as
well as generic medicines;
Consumer products, non prescription medicine and nutrition sales and distribution;
Medical equipment sales and distribution, which include marketing activities;
Raw material sales and distribution, which include veterinary product;
Healthcare services.
ENSEVAL IN BRIEF
More than 40 years in business, Enseval constanly makes the best effort to obtain sustainable growth.
1973 Incorporation
of PT Enseval
1988 Incorporation
of PT Arya Gupta
Cempaka
2003 Incorporation
of
PT
Millenia
Dharma Insani
2007 Incorporation of PT
Enseval Medika Prima and
PT
Global
Chemindo
Megatrading
2013-2015 Makassar, Bandung, Bekasi, Jakarta 1, Kupang, Palu, Balikpapan, Bogor, Jember, RDC
Jakarta, RDC Surabaya, Palembang, Jakarta 2, Padang, Pematang Siantar, Tangerang, Yogyakarta,
Batam, Bengkulu, Tasikmalaya, Semarang, and Surabaya 1 awarded BPOM awards these centres
for Good Distribution Practice in Pharmaceuticals.
2008 Incorporation of PT
Renalmed Tiara Utama
ENSEVAL IN BRIEF
Become Market Leader Through high quality of information Technology system and competent human
resources.
Currently, the Company owns and operates 46 branches and 24 branches under subsidiaries, and 24
sales office located on Indonesia achipelago;
The Company also owns 2 Regional Distribution Center (RDC) located in Jakarta and Surabaya;
For the information technology platform, the Company now is using Oracle E-Business Suite Release
12;
Until the end of December 2014, the Company's operation supported by over than 6,700 employees.
2015 OVERVIEW
AWARD & SERTIFICATION UNTIL MARCH 2015
ORACLE - EXA Trend-Setter Award.
FRONTIER - The Best Building and Managing Corporate Image.
FROST & SULLIVAN - Indonesia Pharmaceutical Distributor of the year.
Department of Animal Husbandry in East Java province - the best distributor of veterinary drug.
HERMINA HOSPITAL GROUP - The Best Pharmaceutical Distributor.
BETHESDA HOSPITAL YOGYAKARTA - The Best Pharmaceutical Distributor.
NIVEA - The Best Weighted Distributor.
Rekor Bisnis Indonesia - Pharmaceutical Distributor with the Most Outlet Coverage.
The Most Powerful Distribution Performance
EXTRA JOSS
KOMIX
2015 OVERVIEW
AWARD & SERTIFICATION UNTIL MARCH 2015
SECTION 2
BUSINESS OVERVIEW
BUSINESS OVERVIEW
NET SALES PER PRODUCTS UNTIL MARCH 31, 2015
*Description of net sales per products as describe below :
Products Portfolio
Consumer Products
1.704.266.238.982
41,82%
Prescription Medicines
1.184.947.877.428
29,08%
697.104.357.456
17,11%
Raw Materials
348.126.299.381
8,54%
Medical Equipment
127.207.289.021
3,12%
Veterinary Products
12.022.562.620
0,30%
1.451.445.616
0,03%
4.075.126.070.504
100%
Total :
10
BUSINESS OVERVIEW
DESCRIPTION OF NET SALES PER PRODUCTS AND THE CONTRIBUTION
3,12%
8,54%
0,30%
0,04%
Consumer Products
Prescription Medicines
Non Prescription Medicines
Raw Materials
Medical Equipment
Veterinary Products
Health Care Services
17,11%
29,08%
11
41,82%
Net Sales
March 2015
Rp4,075.1 billion
BUSINESS OVERVIEW
ALL BUSINESS LINE OF THE COMPANY WERE GREW SIGNIFICANTLY
*Growth of net sales per products as describe below :
Products Portfolio
Growth
Consumer Products
1.763.701.930.954
1.704.266.238.982
(3,37)%
Prescription Medicines
1.146.345.285.055
1.184.947.877.428
3,37%
658.813.480.226
697.104.357.456
5,81%
Raw Materials
331.202.664.581
348.126.299.381
11,86%
Medical Equipment
90.870.076.053
127.207.289.021
39,99%
Veterinary Products
10.693.056.284
12.022.562.620
12,43%
1.174879.724
1.451.445.616
23,54%
3.982.801.372.877
4.075.126.070.504
2,32%
Total :
12
BUSINESS OVERVIEW
GROWTH OF NET SALES 2014 VS 2015
2.32 %
2014
2015
(3.37) %
3.37 %
5.81 %
11.86 %
Total Net
Sales
13
Consumer
Products
Prescription
Medicines
Non
Raw Materials
Prescription
Medicines
39.99 %
Medical
Devices
12.43 %
Veterinary
Products
23.54 %
Health Care
Services
BUSINESS OVERVIEW
THE COMPANYS PRINCIPALS
Prescription
Non-Prescription
Consumer Health
14
BUSINESS OVERVIEW
THE COMPANYS PRINCIPALS
15
BUSINESS OVERVIEW
THE COMPANYS PRINCIPALS
Raw material
16
BUSINESS OVERVIEW
NATIONAL COVERAGE 70 FULL SERVICES BRANCHES & MORE THAN 200,000 DIRECT OUTLET COVERAGE
RDC JAKARTA
RDC SURABAYA
46 BRANCH
24 BRANCH under subsidiaries (TSJ)
24 SALES OFFICE
BUSINESS OVERVIEW
MORE THAN 200,000 DIRECT OUTLET COVERAGE
Type of outlet coveraged by the companys distribution
Covers all trade channels in the market :
General / Traditional
Trade Channel
18
Wholesalers
Retailers
Provision Stores
Convenience Stores
Food & Beverage
Store - Fruit Shops
Cosmetic Stores
etc
Pharmaceutical Trade
Channel
Hypermarkets
Supermarkets
Mini Markets
Departement Stores
etc
Pharmacies
Drugstores
Hospitals
Labs Clinics
Institutions
etc
2015 OVERVIEW
SALES CONTRIBUTION BY CHANNEL (MARCH 2014 VS MARCH 2015)
2014
Pharmaceutical Trade
Modern Trade
2015
General Trade
Pharmaceutical Trade
Modern Trade
23,80%
27,97%
36,65%
40,37%
31,66%
19
General Trade
39,55%
2015 OVERVIEW
SALES CONTRIBUTION BY PRINCIPAL (MARCH 2014 VS MARCH 2015)
2014
External Principal
2015
Internal Principal
External Principal
Internal Principal
21%
33%
67%
79%
20
BUSINESS OVERVIEW
THE COMPANYS MODERN TRADE ACCOUNT
21
BUSINESS OVERVIEW
200,000+ DIRECT OUTLET COVERAGE
Pharmacy; 11.571
Hospital; 1.614
Drugstore; 4.485
Wholesaler; 2.260
Hypermarket, 178
Supermarket; 1.179
Minimarket; 3.115
22
SECTION 3
OPERATIONAL OVERVIEW
OPERATIONAL OVERVIEW
IT INFRASTRUCTURE
Mobile application (Tablet Computer & PDA)
- Supervisor: Team Performance Analysis.
- Salesman & Deliveryman: Faster Order Taking & Faster Information Process.
Global Information System (GIS)
- Application for more in depth sales and territory mapping.
Supported by Enseval Customer Care (ECC)
- In Branches Order Management, Complaint Handling, Basic Product Information.
Customers also can reach Enseval office via Phone, Fax & Email for easy customer ordering.
24
OPERATIONAL OVERVIEW
IT INFRASTRUCTURE
Centralized IT system using Oracle E-Business Solutions
Integrated & Real Time system
Use the best world-class ERP system by Oracle
Complete Oracle E-Business Suite
Oracle Warehouse Management System (WMS)
Advance Supply Chain Planning (ASCP) and Oracle Demantra
Tablet Computer & PDA system E-Mobile
2,300+ PDA used by Supervisors, Salesmen, Deliverymen, & Collectors
Menu: Distribution Plan, Distribution Achievement, Overdue, etc
Provide data security for antivirus by Trend Micro and Sonic Wall
25
OPERATIONAL OVERVIEW
COMPREHENSIVE BUSINESS ACCESS
ENI (Enseval Net Info)
For Principal
26
For Customer
SECTION 4
FINANCIAL OVERVIEW
FINANCIAL OVERVIEW
NET SALES GROWTH
Net Sales
2014
2015
COGS
89.28%
- 0.48%
88.80%
2.32%
1.77%
3.982,80
4.075,13
3.555,88
28
3.618,91
March 31, 2015
(Unaudited)
: COGS in Rp/billion
: COGS in Rp/billion
: COGS Margin
FINANCIAL OVERVIEW
EXPENSE RATIO
Gross Profit
0.48%
Operational Expense
11.20%
10.72%
6.86%
0.22%
5.19%
456,22
426,92
March 31, 2014
(Unaudited)
335,35
318,80
29
8.23%
8.00%
FINANCIAL OVERVIEW
PROFIT GROWTH (MARCH 2014 VS MARCH 2015)
Income Before Tax Expense
Operating Profit
2.71%
0.26%
2.97%
11.79%
3.08%
0.13%
3.21%
0.18%
2.16%
2.34%
6.43%
11.19%
108,12
120,87
(Unaudited)
(Unaudited)
Operating Profit
(Rp/Billion)
Operating Profit Margin
30
122,74
130,63
(Unaudited)
85,85
95,45
(Unaudited)
FINANCIAL OVERVIEW
FINANCIAL POSITION (DEC 2014 VS MARCH 2015)
0.42%
2.74%
6.190,62
4.67%
6.164,52
2.640,74
Dec 31, 2014 March 31, 2015
(Audited)
(Unaudited)
31
2.517,54
(Unaudited)
3.549,88
3.646,98
(Unaudited)
SECTION 5
2015 OVERVIEW
Delivery with
Temperature Controlled Transportation
Temperature Monitoring
Document
STANDARDIZED FACILITIES
STANDARDIZED BRANCHES (FULL SERVICES)
Strong and good relationship with all business players : Principals & Outlets.
Having in aggregate over 100 years of experience senior management team and supported by more than 5000
employees.
Public listed company with professional management that treats all business partners equally with the utmost
transparency and accountability.
Independent business entity with neutrality to ensure fairness to all stakeholders.
Implementation of Continuous Improvement (CONIM) in all business aspects by Ensevals employees in every
level.
This presentation has been prepared solely for use in connection with the release 0f 31 March 2015 unaudited results of the Company. The information
contained in this presentation has not been independently verified. No representation, warranty or undertaking, express or implied, is made as to, and no
reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or the opinions contained herein. None of the Company or
any of their respective affiliates, and their respective commissioners, directors and employees, advisors or representative shall have any liability whatsoever (in
negligence or otherwise) for any loss however arising from any use of this presentation or its contents or otherwise arising in connection with the presentation.
Any decision to purchase or subscribe for securities of the Company should not be made on the basis of the information contained in this presentation.
The presentation is not an offer of securities for sale in the United States. Securities may not be offered or sold in the United States absent registration or an
exemption from registration.
This presentation and its contents are confidential unless they are become generally avaiable as public information in accordance with prevailing laws
regulations (other than as a result of a disclosure by you) and must not be distributed, published or reproduced (in whole or in part) or disclosed by receipents
to any other person. This presentation does not constitute a recommendation regarding the securities of the Company.
This presentation, including the information and opinions contained herein, is provided as the date of this presentation and is subject to change without notice,
including change as a result of the issuance of 31 March 2015 unaudited results of the Company.
This presentation includes "forward-looking statements". These statements contain the words "anticipate", "believe", "intend", "estimate", "expect" and words
of similiar meaning. All statements other than statements of historical facts included in this presentation, including, without limitation, those regarding the
Company's financial position, business strategy, plans and objectives of management for future operations (including development plans, objectives relating to
the Company's products and services and anticipated product launches) are forward-looking statements. Such forward-looking statements are based on
numerous assumptions regarding the Company's present and future business strategies and the environment in which of the Company will operate in the
future. These forward-looking statements speak only ast the date of this presentation. The Company expressly disclaims any obligation or reflection of any
change in the Company's expectations with regard thereto, or any change in events, conditions or circumtances on which any statements is based.
Market data and certain industry forecast used in this presentation were obtained from market research, publicity avaiable information and industry
publications which have not been independently verified, and no presentation is made as to the accuracy of such information.
THANK YOU
For Further Information:
Corporate Secretary
PT Enseval Putera Megatrading Tbk.
Enseval Building
Kawasan Industri Pulogadung
Jalan Pulolentut No. 10
Jakarta 13920 Indonesia
Phone : 62-21-46822422 Fax : 62-21-4609039
Website : www.enseval.com
Email : investor.relations@enseval.com